KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $325.9 million.

  • Globus Medical's Accumulated Expenses rose 2768.31% to $325.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.9 million, marking a year-over-year increase of 2768.31%. This contributed to the annual value of $260.6 million for FY2024, which is 837.19% up from last year.
  • As of Q3 2025, Globus Medical's Accumulated Expenses stood at $325.9 million, which was up 2768.31% from $281.7 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Accumulated Expenses registered a high of $325.9 million during Q3 2025, and its lowest value of $69.9 million during Q1 2021.
  • For the 5-year period, Globus Medical's Accumulated Expenses averaged around $162.2 million, with its median value being $92.2 million (2022).
  • Per our database at Business Quant, Globus Medical's Accumulated Expenses skyrocketed by 109.8% in 2022 and then surged by 16089.03% in 2023.
  • Quarter analysis of 5 years shows Globus Medical's Accumulated Expenses stood at $91.2 million in 2021, then rose by 1.1% to $92.2 million in 2022, then surged by 160.89% to $240.5 million in 2023, then increased by 8.37% to $260.6 million in 2024, then grew by 25.07% to $325.9 million in 2025.
  • Its last three reported values are $325.9 million in Q3 2025, $281.7 million for Q2 2025, and $237.6 million during Q1 2025.